Abbott reorganization

This article was originally published in The Tan Sheet

31 Jul 2000
News

The Tan Sheet

Executive Summary

Ross Products infant formula business remains untouched under new leadership and organization restructuring initiative slated to go into effect Aug. 1. Coinciding with the announced retirement of Abbott President and Chief Operating Officer Robert Parkinson, a new reporting structure will be set in place for the pharmaceuticals and medical products businesses. Ross will remain under the guidance of Senior VP Joy Amundson. The company's decision to leave Ross alone has opened speculation that the infant formula group could be a divestiture candidate

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
Consumer
Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS091474

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS091474

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Abbott reorganization

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert